Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.54L 12.57L 11.59L 21.84L 15Cr 22.23L 1.49Cr 58.27L 7.39Cr 58.53L 57.25L 25Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.81Cr -2.61Cr -2.41Cr -4.54Cr -309.11Cr -4.62Cr -31Cr -12Cr -153.52Cr -12Cr -12Cr -516.28Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
Rosemary Mazanet
BRD | Director/Board Member | 70 | 27/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.75% | 15.59L | |
| -1.40% | +2.59% | -1.71% | +11.28% | 4.94TCr | |
| -1.95% | +12.20% | +25.60% | +4.33% | 3.91TCr | |
| -2.88% | -0.81% | +403.60% | +615.01% | 4.09TCr | |
| -2.64% | -3.49% | +4.45% | +46.82% | 3.58TCr | |
| -1.74% | +8.42% | +8.85% | +48.87% | 3.05TCr | |
| -2.70% | -3.69% | - | - | 1.66TCr | |
| -1.34% | -5.02% | +33.70% | +125.61% | 1.61TCr | |
| -0.83% | -0.77% | -2.78% | -34.57% | 1.28TCr | |
| -0.64% | +2.65% | +1.25% | +8.92% | 1.37TCr | |
| Average | -3.99% | +2.62% | +52.55% | +81.50% | 2.55TCr | |
| Weighted average by Cap. | -1.86% | +6.72% | +77.05% | +128.94% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 12.94L 12.02L 11.08L 20.88L 14Cr 21.26L 1.42Cr 55.71L 7.06Cr 55.95L 54.73L 24Cr | 8L 7L 6L 6L 11L 7.49Cr 11.2L 74.96L 29.35L 3.72Cr 29.48L 28.83L 13Cr |
| Net income | -4.42Cr -3.84Cr -3.56Cr -3.29Cr -6.19Cr -421.69Cr -6.3Cr -42Cr -17Cr -209.43Cr -17Cr -16Cr -704.3Cr | -3.95Cr -3.43Cr -3.18Cr -2.94Cr -5.53Cr -376.9Cr -5.63Cr -38Cr -15Cr -187.19Cr -15Cr -15Cr -629.5Cr |
| Net Debt | -6.36Cr -5.53Cr -5.13Cr -4.73Cr -8.92Cr -607.53Cr -9.08Cr -61Cr -24Cr -301.73Cr -24Cr -23Cr -1.01TCr | -3.39Cr -2.95Cr -2.74Cr -2.52Cr -4.76Cr -323.99Cr -4.84Cr -32Cr -13Cr -160.91Cr -13Cr -12Cr -541.13Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
